Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lycia Therapeutics logo — Building the leading extracellular protein degradation compa...

Lycia Therapeutics

Building the leading extracellular protein degradation company

Founded 2020 United States South San Francisco, United States 38 employees

General Information

Company Name Lycia Therapeutics
Founded Year 2020
Location United States South San Francisco, United States +1
Employees 38
Social

Get notified when Lycia Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Lycia Therapeutics

At Lycia, we aim to eliminate the source of disease using the power of extracellular protein degradation. Our novel LYTAC therapeutics are designed to bind and remove disease-causing extracellular proteins by directing them into the cell for degradation via the lysosome. Focused initially on autoimmune and inflammatory diseases, our platform addresses gaps in targeting proteins outside the cell, offering new hope to patients who urgently need better options.

No funding data available for Lycia Therapeutics yet.

Get notified when Lycia Therapeutics raises funding

Lycia Therapeutics Alternatives & Competitors

Lycia Therapeutics vs
Gate Bioscience
Gate Bioscience United States

A new frontier of protein elimination

Series B
41 employees
Lycia Therapeutics vs
Avilar Therapeutics
Avilar Therapeutics United States

Pioneering the discovery and development of extracellular protein degraders.

Seed
25 employees
Biotechnology, Pharmaceutical
Lycia Therapeutics vs
Metatissue
Metatissue Portugal

Advancing 3D Cell Culture

12 employees

FAQ About Lycia Therapeutics

Building the leading extracellular protein degradation company
Lycia Therapeutics was founded in 2020.
Lycia Therapeutics is headquartered in South San Francisco, United States.
Lycia Therapeutics has approximately 38 employees.
Top alternatives and competitors to Lycia Therapeutics include Gate Bioscience, Avilar Therapeutics, Metatissue, Draupnir Bio, PineTree Therapeutics Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lycia Therapeutics and Gate Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Lycia Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy